5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum.

Let's take a closer look at five of this past week's biggest scorchers.

Company

July 6 Weekly Gain My Watchlist
Nanosphere (Nasdaq: NSPH  ) $3.91 45% Add
Supernus Pharmaceuticals (Nasdaq: SUPN  ) $12.05 29% Add
MannKind (Nasdaq: MNKD  ) $5.42 34% Add
Netflix (Nasdaq: NFLX  ) $81.89 20% Add
Yelp (NYSE: YELP  ) $25.30 11% Add

Source: Barron's.

Nanosphere moved sharply higher after Jefferies analyst Jon Wood upgraded the company with a bullish buy rating and a $5 price target. Wood is encouraged by Nanosphere's recently approved blood infection test.

Supernus Pharmaceuticals soared 82% two weeks ago after the Food and Drug Administration tentatively approved the central nervous system treatment specialist's Trokendi drug. Momentum continued to move the stock higher last week.

Insider buying, the announcement of an upcoming conference presentation, and an analyst telling The Wall Street Journal that MannKind is a compelling acquisition target helped move the potential game changer in diabetes treatment higher.

Netflix had a double dose of good news. Citigroup's analyst issued a bullish note, pointing out that the company is trading for just 12 times the earnings of its stateside business. CEO Reed Hastings also revealed that the company served more than a billion hours of monthly video streams for the first time last month.

Yelp posted double-digit gains after reports suggested that the dining review specialist's social critiques would be incorporated into Apple's new mapping platform.

More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.

The Motley Fool owns shares of Netflix. Motley Fool newsletter services have recommended buying shares of Netflix. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story, except for Netflix. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.


Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 09, 2012, at 10:51 AM, AceOfSaves wrote:

    I think you're mistaken about MNKD at $5.42. It is currently at $2.81 and it did not even break the $3 mark last week.

  • Report this Comment On July 11, 2012, at 6:20 PM, WCoastGuynCA wrote:

    In regards to Mannkind the key question is how will the company be financed going into the first quarter of 2013 through the F.D.A. decision on Afreeza. The two options are a new secondary offering or having the company's billionaire C.E.O. loan the company another $60,000,000. The former would take the share price to the $2.00 range and the latter to the $4.00 range. In either case I would expect the share price to move higher as the decision date approached.

    Place your bets.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1936466, ~/Articles/ArticleHandler.aspx, 10/24/2014 5:46:38 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement